Tokyo, June 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061904) titled 'Multi-omics study on host pathophysiology caused by cancer' on June 14.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University
Condition:
Condition - Primary or metastatic malignant liver tumor
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the pathophysiological changes in host hepatocytes and stromal cells associated with malignant liver tumors by multi-omics analysis of surgically resected tissues, blood, bile, and ascites samples.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - 1. Patients with malignant liver tumors
2. Patients who undergo or have undergone surgical resection at Tohoku University Hospital
3. Patients aged 18 years or older
4. For prospectively collected samples, patients who provide written informed consent to participate in this study
Key exclusion criteria - 1. Patients who have not been informed that they have a malignant tumor
2. Patients who are unable to voluntarily provide informed consent
Target Size - 30
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 12 Month 03 Day
Date of IRB - 2026 Year 06 Month 12 Day
Anticipated trial start date - 2026 Year 01 Month 15 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070836
Disclaimer: Curated by HT Syndication.
